Histogram analysis of apparent diffusion coefficient at 3.0 T in urinary bladder lesions: Correlation with pathologic findings

Academic Radiology

Volumn 21, Issue 8, 2014, Pages 1027-1034

  Suo, Shi Teng ^a   Chen, Xiao Xi ^a   Fan, Yu ^a   Wu, Lian Ming ^a   Yao, Qiu Ying ^a   Cao, Meng Qiu ^a   Liu, Qiang ^a   Xu, Jian Rong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apparent diffusion coefficient; Bladder; Histogram analysis; Magnetic resonance imaging; Pathology

Indexed keywords

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; BLADDER CARCINOMA; BLADDER INJURY; CANCER STAGING; CONTROLLED STUDY; CYSTECTOMY; CYSTITIS; DIAGNOSTIC VALUE; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ENTROPY; FEMALE; GRANULOMATOUS INFLAMMATION; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR DIFFERENTIATION; UNDIFFERENTIATED CARCINOMA; ALGORITHM; BLADDER TUMOR; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION TENSOR IMAGING; IMAGE ENHANCEMENT; MATHEMATICAL COMPUTING; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; STATISTICS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; DATA INTERPRETATION, STATISTICAL; DIFFUSION TENSOR IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM STAGING; NUMERICAL ANALYSIS, COMPUTER-ASSISTED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; URINARY BLADDER NEOPLASMS;

EID: 84904052747     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2014.03.004     Document Type: Article

References (29)

1. Lu Y.-Y., Chen J.-H., Liang J.-A., et al. Clinical value of FDG PET or PET/CT in urinary bladder cancer: a systemic review and meta-analysis. Eur J Radiol 2012, 81:2411-2416.
2. Wu L.-M., Chen X.-X., Xu J.-R., et al. Clinical value of T2-weighted imaging combined with diffusion-weighted imaging in preoperative T staging of urinary bladder cancer: a large-scale, multiobserver prospective study on 3.0-T MRI. Acad Radiol 2013, 20:939-946.
3. Matsuki M., Inada Y., Tatsugami F., et al. Diffusion-weighted MR imaging for urinary bladder carcinoma: initial results. Eur Radiol 2007, 17:201-204.
4. Watanabe H., Kanematsu M., Kondo H., et al. Preoperative T staging of urinary bladder cancer: does diffusion-weighted MRI have supplementary value?. Am J Roentgenol 2009, 192:1361-1366.
5. Takeuchi M., Sasaki S., Ito M., et al. Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009, 251:112-121.
6. Avcu S., Koseoglu M., Ceylan K., et al. The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions. Brit J Radiol 2011, 84:875-882.
7. Padhani A.R., Liu G., Mu-Koh D., et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (New York, NY) 2009, 11:102.
8. Daǧgülli M., Onur M.R., Firdolaş F., et al. Role of diffusion MRI and apparent diffusion coefficient measurement in the diagnosis, staging and pathological classification of bladder tumors. Urol Int 2011, 87:346-352.
9. El-Assmy A., Abou-El-Ghar M.E., Mosbah A., et al. Bladder tumour staging: comparison of diffusion-and T2-weighted MR imaging. Eur Radiol 2009, 19:1575-1581.
10. Giannarini G., Petralia G., Thoeny H.C. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature. Eur Urol 2012, 61:326-340.
11. Ahn S.J., Choi S.H., Kim Y.-J., et al. Histogram analysis of apparent diffusion coefficient map of standard and high B-value diffusion MR imaging in head and neck squamous cell carcinoma: a correlation study with histological grade. Acad Radiol 2012, 19:1233-1240.
12. Pope W.B., Kim H.J., Huo J., et al. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. Radiology 2009, 252:182-189.
13. Bull J.G., Saunders D.E., Clark C.A. Discrimination of paediatric brain tumours using apparent diffusion coefficient histograms. Eur Radiol 2012, 22:447-457.
14. Kobayashi S., Koga F., Yoshida S., et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol 2011, 21:2178-2186.
15. Funatsu H., Imamura A., Takano H., et al. Can pretreatment ADC values predict recurrence of bladder cancer after transurethral resection?. Eur J Radiol 2012, 81:3115-3119.
16. Rosenkrantz A.B., Mussi T.C., Spieler B., et al. High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results. J Magn Reson Imaging 2012, 35:1478-1483.
17. Sobin L.H., Gospodarowicz M.K., Wittekind C. TNM classification of malignant tumours 2011, Wiley-Blackwell, New York.
18. Tozer D.J., Jäger H.R., Danchaivijitr N., et al. Apparent diffusion coefficient histograms may predict low-grade glioma subtype. NMR Biomed 2007, 20:49-57.
19. Kang Y., Choi S.H., Kim Y.-J., et al. Gliomas: histogram analysis of apparent diffusion coefficient maps with standard-or high-b-value diffusion-weighted MR imaging-correlation with tumor grade. Radiology 2011, 261:882-890.
20. Pope W., Lai A., Mehta R., et al. Apparent diffusion coefficient histogram analysis stratifies progression-free survival in newly diagnosed bevacizumab-treated glioblastoma. Am J Neuroradiol 2011, 32:882-889.
21. Downey K., Riches S.F., Morgan V.A., et al. Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images. Am J Roentgenol 2013, 200:314-320.
22. Heo S.H., Shin S.S., Kim J.W., et al. Pre-treatment diffusion-weighted MR imaging for predicting tumor recurrence in uterine cervical cancer treated with concurrent chemoradiation: value of histogram analysis of apparent diffusion coefficients. Korean J Radiol 2013, 14:616-625.
23. Fujimoto K., Tonan T., Azuma S., et al. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade. Radiology 2011, 258:739-748.
24. Kobayashi S., Koga F., Kajino K., et al. Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. J Magn Reson Imaging 2014, 39:172-178.
25. Koh D.-M., Collins D.J. Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Roentgenol 2007, 188:1622-1635.
26. O'Brien T., Cranston D., Fuggle S., et al. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 1995, 55:510-513.
27. Kim C.K., Park B.K., Kim B. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. Am J Roentgenol 2010, 194:W33-W37.
28. Shi Z., Yang Z., Zhang G., et al. Characterization of texture features of bladder carcinoma and the bladder wall on MRI: initial experience. Acad Radiol 2013, 20:930-938.
29. Thörmer G., Otto J., Reiss-Zimmermann M., et al. Diagnostic value of ADC in patients with prostate cancer: influence of the choice of b values. Eur Radiol 2012, 22:1820-1828.